Sep 062012
Michael Higgins, Managing Director, Brinson Patrick
Michael Higgins
Vernon Bernardino, Brinson Patrick
Vernon Bernardino

At the beginning of the year, Brinson Patrick quietly launched an equity research department to better serve its life sciences clients. They knew us, trusted us, and knew we knew their business inside and out, and adding the department made sense as an additional service to our DOCS® ATM financing vehicle.

It began as a team of one, with Michael Higgins, former managing director and senior specialty pharmaceuticals analyst with Rodman & Renshaw, LLC. Now it’s a powerhouse team of two, with the addition of senior analyst Vernon Bernardino, an 11-year veteran of biotech and pharmaceutical financial coverage.

We welcome Vernon, and look forward to leveraging our increased expertise to help clients develop successful financing strategies.

Mar 222012

Today we are announcing the initiation of research coverage of Akorn, Inc.(NASDAQ: AKRX), a company that develops, manufactures and markets multisource and branded pharmaceuticals. The report, issued by our analyst Michael Higgins, is the first one of the firm’s new equity research department, which was established in January.

Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.